![]() |
|
|
Molecular Pharmacology, Vol 14, 69-76, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Pharmacology and Experimental Therapeutics and of Psychiatry and the Behavioral
Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205
[3H]Naloxone and [3H]dihydromorphine bind in a saturable fashion and with high
affinity to membrane preparations of guinea pig kidney and liver. Binding in guinea
pig kidney displays "reversed" stereospecificity, with pharmacologically inactive dextrallorphan being more potent than the known pharmacologically active levallorphan.
Opiate agonists tend to be more potent than their corresponding antagonists in
competing for [3H]opiate binding in guinea pig kidney. Unlike brain opiate receptors,
in which sodium and manganese selectively decrease and increase, respectively, the
binding of [3H]opiate agonists, these ions have no selective effect on the binding of
[3H]opiates in guinea pig kidney and liver. The opioid peptides Met-enkephalin and
-endorphin and the opiates etorphine and diprenorphine, which have very high affinity
for brain opiate receptors, have negligible effects on [3H]opiate binding in guinea pig
kidney.
Note:
ACKNOWLEDGMENT
We thank Adele Snowman for outstanding technical assistance.